Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care
Recruiting
N/A
Interventional Study
Angina
Acute Bronchiolitis
Acute Bronchitis
COPD Exacerbation (AECOPD)
Laryngitis
Acute Otitis Media (AOM)
Serous or Congestive Otitis
Viral Respiratory Infection (e.g., Influenza)
Community-Acquired Pneumonia (CAP)
Rhinitis / Nasopharyngitis
Acute Sinusitis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 4,500 (estimated)
- Sponsor
- University Hospital, Caen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Antimicrobial resistance (AMR), considered one of the greatest global threats by the WHO, justifies the development of initiatives to promote appropriate antibiotic use-especially in primary care, where most antibiotics in France are prescribed and where misuse remains common.
We are proposing a cluster-randomized controlled trial to evaluate the effectiveness of a bimodal intervention combining:…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
\- Patient seen in consultation for an upper or lower respiratory tract infection (Angina, Acute bronchiolitis, Acute bronchitis, COPD exacerbation (AECOPD), Laryngitis, Acute otitis media (AOM), Serous or congestive otitis, Viral respiratory infection (e.g., influenza), Communi…
Contacts